ClavystBio is a Singapore-based venture capital firm and life sciences venture builder investing in biotechnology, medtech, digital health, pharmaceuticals and oncology. It backs early-stage company creation and growth, with activity extending to later-stage venture rounds, and has acted as a co-lead investor. The firm invests across Singapore and the United States and supports commercialization through incubation, investment and partnerships.